C

Cardiology Consultants of Philadelphia | Yardley

Research site

(Unclaimed)

Location

301 Oxford Valley Road Suite 901, Yardley, Pennsylvania, United States of America

Site insights

Top conditions

Top treatments

Apixaban

Ibuprofen

Tirzepatide

Rilonacept

Clopidogrel

Celecoxib

Naproxen

LY3298176

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 17 total trials

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Enrolling

Atrial Fibrillation

Drug: Apixaban Placebo

Drug: Milvexian

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT)

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardio...

Active, not recruiting

Type 2 Diabetes Mellitus

Drug: Tirzepatide

Drug: Dulaglutide

Benefits of µCor in Ambulatory Decompensated Heart Failure (BMADHF)

Subjects meeting the inclusion/exclusion criteria will wear the µCor for at least 90 days. During the study, clinic follow up will occur every 30 day...

Active, not recruiting

Heart Failure

Device: µCor